Free Trial
ASX:BOT

Botanix Pharmaceuticals (BOT) Stock Price, News & Analysis

Botanix Pharmaceuticals logo

About Botanix Pharmaceuticals Stock (ASX:BOT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.63 million shs
Average Volume
N/A
Market Capitalization
A$912.82 million
P/E Ratio
N/A
Dividend Yield
2.96%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Botanix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

BOT Stock News Headlines

BOT - Botanix Pharmaceuticals Ltd Chart - Morningstar
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Botanix Pharmaceuticals Limited (BOT.AX)
See More Headlines

BOT Stock Analysis - Frequently Asked Questions

Botanix Pharmaceuticals Limited (ASX:BOT) announced its quarterly earnings results on Thursday, February, 28th. The company reported ($0.01) earnings per share for the quarter. Botanix Pharmaceuticals had a negative trailing twelve-month return on equity of 18.00% and a negative net margin of 670.20%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Botanix Pharmaceuticals investors own include Alphabet (GOOG), Meta Platforms (META), Arafura Rare Earths (ARU), Canopy Growth (CGC), Manning & Napier (MN), (STB.TO) (STB) and (YCB) (YCB).

Company Calendar

Last Earnings
2/28/2019
Today
7/06/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:BOT
CIK
N/A
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$13.87 million
Net Margins
-670.20%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$2.07 million
Price / Cash Flow
1.50
Book Value
A$0.07 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,810,000,000
Free Float
N/A
Market Cap
A$912.82 million
Optionable
Not Optionable
Beta
1.71
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (ASX:BOT) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners